BFONX
Price
$21.64
Change
-$0.69 (-3.09%)
Updated
Feb 21 closing price
Net Assets
53.29M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

BFONX vs GFACX

Header iconBFONX vs GFACX Comparison
Open Charts BFONX vs GFACXBanner chart's image
Biondo Focus Investor
Price$21.64
Change-$0.69 (-3.09%)
VolumeN/A
Net Assets53.29M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
BFONX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BFONX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFONX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BFONX (53.3M). BFONX (0.00) and GFACX (0.00) have matching dividends . BFONX was incepted earlier than GFACX: BFONX (15 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. BFONX (8.00). GFACX has a lower initial minimum investment than BFONX: GFACX (250) vs BFONX (1000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. BFONX (7.35). GFACX return over 5 years is better than : 32.83 vs. BFONX (10.30).
BFONXGFACXBFONX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years24 years-
Gain YTD0.6042.98020%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets53.3M304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.3510.1572%
Returns for 3 years12.8217.6972%
Returns for 5 years10.3032.8331%
Returns for 10 years27.7155.6350%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding